Table 1 Patient characteristics at baseline.

From: Transarterial chemoembolization with medium-sized doxorubicin-eluting Callisphere is safe and effective for patients with hepatocellular carcinoma

Characteristics, n (%)

Small bead group (n = 34)

Medium bead group (n = 26)

P value

Diagnosis#

   Primary

18 (52.9)

14 (53.8)

0.342

   Metastatic

16 (47.1)

12 (46.2)

0.251

Index tumor size (cm)

6.5 ± 1.2

5.8 ± 1.5

0.171

ECOG score

   0

19 (55.9)

14 (53.8)

0.371

   1–2

15 (44.1)

12 (46.2)

0.228

Child-Pugh score

   A

20 (58.8)

15 (57.7)

0.294

   B

14 (41.2)

11 (42.3)

0.183

Prior therapy for cancer

   Radiofrequency ablation

17 (50.0)

16 (61.5)

0.421

   Systemic chemotherapy

17 (50.0)

10 (38.5)

0.203

  1. #primary: HCC without intrahepatic metastasis.
  2. metastatic: HCC with intrahepatic metastasis.
Back to article page